Image

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Participate in a study for monitoring specific breast cancer markers.

Recruiting
18 years and older
All
Phase N/A
This study looks at a new way to watch hormone receptor positive HER2-negative metastatic breast cancer. The study checks if using blood tests called *serum tumor markers* (STMs) to monitor cancer spread works as well as the usual way of using scans. If you join the study, you'll be put in one of two groups. One group will carry on with regular scans every 12 weeks, while the other group will have blood tests every 4-8 weeks and scans only if those tests show something might be wrong. **Key Points:** - The study lasts up to 312 weeks, and you'll need regular check-ups. - You must have certain blood tests before joining and during the study. - The study's goal is to see if the new method is just as good but costs less and causes less stress. If you have certain health conditions like untreated B12 deficiency or brain tumors, you can't join. Also, if you're pregnant or have had other cancers recently, you might not be eligible. You'll need to agree to the study rules and give consent to participate.
Study details
    Anatomic Stage IV Breast Cancer AJCC v8
    Estrogen Receptor Positive
    HER2/Neu Negative
    Progesterone Receptor Positive
    Prognostic Stage IV Breast Cancer AJCC v8
    Elevated CA15-3 or CEA or CA27-29

NCT03723928

SWOG Cancer Research Network

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.